Affiliation:
1. School of Biomedical Sciences The University of Western Australia Perth Western Australia Australia
2. Colorectal Cancer Unit St John of God Subiaco Hospital Perth Western Australia Australia
3. School of Medicine The University of Western Australia Perth Western Australia Australia
Abstract
AbstractMetachronous colorectal cancer (CRC) metastasis occurs due to micrometastatic disease, in up to 23% of patients who have undergone curative‐intent treatment. Metachronous metastasis tends to occur within 2 years of initial treatment. Diagnosis relies on posttreatment surveillance strategies. Care for patients with metachronous CRC metastasis is complex and requires careful multidisciplinary consideration. Those with isolated and technically resectable diseases are recommended to undergo metastasectomy with adjunct chemotherapy, however, survival, even after curative‐intent resection, is poor.
Subject
Oncology,General Medicine,Surgery